Clinical Trials Directory

Trials / Completed

CompletedNCT00674570

Veteran Stress and Learning Study

Effects of Hydrocortisone and D-Cycloserine on Fear Extinction in Veterans With Posttraumatic Stress Disorder

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
111 (actual)
Sponsor
VA Office of Research and Development · Federal
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This is a research study examining the use of two medications, Hydrocortisone and D-Cycloserine, compared to an inactive substance (placebo), on their ability to reduce fear responses and memory of fear in Veterans with symptoms of Posttraumatic Stress Disorder (PTSD). These responses will be tested using a fear learning and memory task administered by computer.

Conditions

Interventions

TypeNameDescription
DRUGHydrocortisone25 mg/oral one hour prior to extinction task
DRUGD-Cycloserine50 mg/oral one hour prior to extinction task
DRUGPlaceboOne hour prior to extinction task

Timeline

Start date
2009-01-13
Primary completion
2015-06-22
Completion
2015-06-22
First posted
2008-05-08
Last updated
2019-05-30
Results posted
2019-05-30

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT00674570. Inclusion in this directory is not an endorsement.